Dr. Paz-Ares Discusses the Use of Pemetrexed for NSCLC | OncLive

Dr. Paz-Ares Discusses the Use of Pemetrexed for NSCLC

June 17, 2011

Dr. Paz-Ares From Seville University Hospital Discusses the Use of Pemetrexed for NSCLC

Luis Paz-Ares, MD, PhD the chair of oncology at Seville University Hospital in Spain discusses the use of pemetrexed in advanced nonsquamous non—small cell lung cancer.


x